Cite Filings / ABOS
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0001576885

  • Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364108129
Phone
+1 617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
Filings Financials Insiders Search text
All 365 Financials 79 Shareholder Meetings 6 Executive Compensation 67 Insider Trading 140 Beneficial Ownership Interest 26 Business Combinations 57 Public Offerings 26 Mutual Funds and ETFs 5 Others 93
›
Filed in
  1. No filings match these filters. Clear filters
  2. SC 13G Stake Amended Statement of Ownership 2022-02-14
  3. SC 13G Stake Amended Statement of Ownership 2022-02-04
  4. SC 13G Stake Amended Statement of Ownership 2022-01-27
  5. SC 13D/A Stake Beneficial Ownership Report 2021-09-13
  6. SC 13D Stake ● Beneficial Ownership Report 2021-07-16
  7. SC 13G Stake Amended Statement of Ownership 2021-07-13

Page 2 of 2 · 26 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…